Brief: Tenax Therapeutics CFO Michael Jebsen To Separate From Co

Tenax Therapeutics

14/10/2021 21:47

Oct 14 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX THERAPEUTICS INC -  CFO MICHAEL B. JEBSEN TO
SEPARATE FROM
COMPANY EFFECTIVE OCTOBER 29, 2021
    * TENAX THERAPEUTICS INC -  CHRISTOPHER T. GIORDANO WILL
ASSUME
POSITION OF PRESIDENT OF COMPANY
    * TENAX THERAPEUTICS INC -  ELIOT M. LURIER NAMED INTERIM
CHIEF
FINANCIAL OFFICER OF COMPANY

Source text for Eikon: [https://bit.ly/3FNaqfn]
Further company coverage:  TENX.O 

 ((Reuters.Briefs@thomsonreuters.com;))